Howard Lee's most recent trade in Amphastar Pharmaceuticals Inc was a trade of 11,402 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 11,402 | 11,402 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 5,122 | 152,899 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.01 per share. | 02 Jun 2025 | 923 | 151,976 (0%) | 0% | 26.0 | 24,007 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 6,864 | 6,864 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 3,076 | 148,356 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.04 per share. | 03 Jun 2024 | 579 | 147,777 (0%) | 0% | 42.0 | 24,341 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 10 Jun 2023 | 375 | 145,280 (0%) | 0% | 45.7 | 17,126 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 7,016 | 7,016 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 2,716 | 145,655 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale of securities on an exchange or to another person at price $ 45.02 per share. | 01 Jun 2023 | 16,679 | 142,939 (0%) | 0% | 45.0 | 750,960 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 16,679 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.69 per share. | 01 Jun 2023 | 16,679 | 159,618 (0%) | 0% | 16.7 | 278,373 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 10,984 | 10,984 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,163 | 142,939 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale of securities on an exchange or to another person at price $ 37.79 per share. | 06 Jun 2022 | 10,291 | 138,776 (0%) | 0% | 37.8 | 388,859 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2022 | 10,291 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.11 per share. | 06 Jun 2022 | 10,291 | 149,067 (0%) | 0% | 17.1 | 176,079 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale of securities on an exchange or to another person at price $ 34.93 per share. | 23 May 2022 | 10,000 | 138,776 (0%) | 0% | 34.9 | 349,323 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 10,000 | 10,291 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.11 per share. | 23 May 2022 | 10,000 | 148,776 (0%) | 0% | 17.1 | 171,100 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 17,182 | 17,182 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale of securities on an exchange or to another person at price $ 19.31 per share. | 07 Jun 2021 | 8,000 | 138,933 (0%) | 0% | 19.3 | 154,508 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jun 2021 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.43 per share. | 07 Jun 2021 | 8,000 | 146,933 (0%) | 0% | 16.4 | 131,440 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.43 per share. | 07 Jun 2021 | 7,827 | 140,741 (0%) | 0% | 16.4 | 128,598 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale of securities on an exchange or to another person at price $ 19.28 per share. | 07 Jun 2021 | 7,827 | 132,914 (0%) | 0% | 19.3 | 150,941 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jun 2021 | 7,827 | 8,000 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 6,019 | 138,933 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.43 per share. | 20 May 2021 | 10,000 | 142,914 (0%) | 0% | 16.4 | 164,300 | Common Stock |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 10,000 | 15,827 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Howard Lee | Director | Sale of securities on an exchange or to another person at price $ 19.74 per share. | 20 May 2021 | 10,000 | 132,914 (0%) | 0% | 19.7 | 197,354 | Common Stock |